High affinity nerve growth factor receptor — Drug Target

All drugs that target High affinity nerve growth factor receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Recombinant Human Nerve Growth Factor [EPC] · Kinase Inhibitor [EPC]

Marketed (4)

• Rozlytrek · Roche · Oncology
  Rozlytrek works by blocking the activity of a specific protein called the nerve growth factor receptor.
• Oxervate · Dompe farmaceutici s.p.a. · Recombinant Human Nerve Growth Factor [EPC] · Oncology
  Oxervate works by mimicking the natural nerve growth factor to stimulate nerve regeneration and promote healing in the cornea.
• Vitrakvi · Bayer · Kinase Inhibitor [EPC] · Oncology
  Vitrakvi works by blocking the activity of a specific protein called the nerve growth factor receptor.
• Oxervate · Dompe farmaceutici s.p.a. · Recombinant Human Nerve Growth Factor [EPC] · Neuroscience
  Oxervate works by binding to the high affinity nerve growth factor receptor to stimulate nerve growth and repair.